Recursion Pharmaceuticals - Class A (RXRX)'s 30-day implied volatility (IV30) was 87.8% at the close on October 16, 2026, up from 82.6% the day before, against a 52-week range of 42.5% to 123.9%. Its 20-day historical volatility was 100.5%.
Data as of October 16, 2026.